Biotech · Private company
Antag Therapeutics
Track this companyFree. Adds Antag Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- AT673 high dosePhase 2 · Adults With Overweight/Obesity and Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- AT673 low dosePhase 2 · Adults With Overweight/Obesity and Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or ObesityPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 19, 2026ClinicalTrials.gov NCT07724340 · fetched Nov 12, 2026